Bean Sally T, Smith Maxwell J
Ethicist & Policy Advisor, Sunnybrook Health Sciences Centre.
Can J Public Health. 2016 Mar 16;106(8):e467-9. doi: 10.17269/cjph.106.5083.
Electronic cigarettes (e-cigarettes) are battery-powered devices that heat a liquid containing either vegetable glycerin or propylene glycol in combination with nicotine and/or flavours; an aerosol is produced that is inhaled by the user. Health Canada currently prohibits the importation, marketing or selling of e-cigarettes containing nicotine, although they can be easily purchased. Because of the availability of e-cigarettes, patients and visitors to health care organizations (HCOs) are inquiring about their use within and on the grounds of those facilities. We contend that in provinces or municipalities where e-cigarette use has not been restricted, HCOs should develop institutional policies to do so. We argue that the following reasons collectively justify measures to restrict the use of e-cigarettes within HCOs: unknown long-term safety, uncertain effectiveness in harm reduction, the conflict with the mission of HCOs to promote health, the potential negative health impacts on vulnerable patients with a compromised health status, and the risk of re-normalization of smoking. However, because of the rapidly developing evidence base in this area, HCOs should remain responsive to emerging evidence regarding the status of e-cigarettes as an effective harm reduction tool.
电子烟是一种由电池供电的装置,它加热一种含有蔬菜甘油或丙二醇并与尼古丁和/或香料混合的液体;产生的气溶胶被使用者吸入。加拿大卫生部目前禁止进口、销售含尼古丁的电子烟,尽管它们很容易买到。由于电子烟的可得性,医疗保健机构(HCOs)的患者和访客正在询问在这些机构内部及其场地使用电子烟的情况。我们认为,在尚未限制电子烟使用的省份或直辖市,HCOs应制定相关机构政策来加以限制。我们认为,以下原因共同证明了在HCOs内限制使用电子烟的措施是合理的:长期安全性未知、减少危害的有效性不确定、与HCOs促进健康的使命相冲突、对健康状况不佳的脆弱患者可能产生负面健康影响以及吸烟重新常态化的风险。然而,由于该领域的证据基础迅速发展,HCOs应继续关注有关电子烟作为一种有效减少危害工具的地位的新出现证据。